CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net income	$ 7,397	$ 1,461
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	17,052	15,562
Amortization of deferred financing costs charged to interest expense	1,839	2,182
Stock-based compensation expense	1,898	1,922
Deferred taxes, net	(3,175)	(4,604)
Impairment loss of long-lived asset	0	7,673
Changes in operating assets and liabilities
Accounts receivable	9,270	6,845
Other assets	3,276	1,757
Accrued payroll	(946)	(3,477)
Accounts payable and accrued liabilities	(4,414)	(75)
Other liabilities	(4,831)	1,787
Net cash provided by operating activities	27,366	31,033
Investing activities
Business acquisition, net of cash acquired	0	(180,572)
Purchase of equipment and improvements	(836)	(625)
Net cash used in investing activities	(836)	(181,197)
Financing activities
Proceeds from revolving line of credit	361,720	205,268
Repayment of revolving line of credit	(359,208)	(195,721)
Proceeds from debt obligations	0	168,000
Repayments of debt obligations	(27,313)	(20,188)
Payments of deferred financing costs	0	(7,666)
Proceeds from issuance of common stock upon exercise of options and warrants	261	1,108
Payment of tax obligations resulting from net exercise of stock options	(1,863)	(650)
Net cash (used in) provided by financing activities	(26,403)	150,151
Net change in cash	127	(13)
Cash - beginning of year	215	228
Cash - end of year	342	215
Supplemental disclosures of cash flow information
Cash paid during the year for interest	16,043	14,153
Cash paid during the year for income taxes	3,264	5,604
Supplemental disclosures of non-cash activity
Common stock surrendered for the exercise of stock options	$ 2,822	$ 238